Review of the Potential Therapeutic Effects and Molecular Mechanisms of Resveratrol on Endometriosis

References

• Andres MP, Arcoverde FVL, Souza CCC, Fernandes LFC, Abrão MS, Kho RM. Extrapelvic endometriosis: a systematic review. J Minim Invasive Gynecol. 2020;27(2):373–389. doi:10.1016/j.jmig.2019.10.004
   PubMed Web of Science ®Google Scholar
• Zondervan KT, Becker CM, Missmer SA, Longo DL. Endometriosis. N Engl J Med. 2020;382(13):1244–1256. doi:10.1056/NEJMra1810764
   PubMed Web of Science ®Google Scholar
• Garcia-Fernandez J, García-Velasco JA. Endometriosis and reproduction: what we have learned. Yale J Biol Med. 2020;93(4):571–577.
   PubMed Web of Science ®Google Scholar
• Prosperi Porta R, Sangiuliano C, Cavalli A, et al. Effects of breastfeeding on endometriosis-related pain: a prospective observational study. Int J Environ Res Public Health. 2021;18(20):10602. doi:10.3390/ijerph182010602
   PubMed Web of Science ®Google Scholar
• Armour M, Lawson K, Wood A, Smith CA, Abbott J, Thumbikat P. The cost of illness and economic burden of endometriosis and chronic pelvic pain in Australia: a national online survey. PLoS One. 2019;14(10):e0223316. doi:10.1371/journal.pone.0223316
   PubMed Web of Science ®Google Scholar
• Halici BNA, Aktoz F, Kabakci M, Kiran G, Ozcan P. Analysis of preoperative and postoperative quality of life, sexual function, and sleep in patients with endometriosis: a prospective cohort study. Arch Gynecol Obstet. 2022;307(1):113–120. doi:10.1007/s00404-022-06562-9
   PubMed Web of Science ®Google Scholar
• Kim HS, Kim TH, Chung HH, Song YS. Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis. Br J Cancer. 2014;110(7):1878–1890. doi:10.1038/bjc.2014.29
   PubMed Web of Science ®Google Scholar
• Kajiyama H, Suzuki S, Yoshihara M, et al. Endometriosis and cancer. Free Radic Biol Med. 2019;133:186–192. doi:10.1016/j.freeradbiomed.2018.12.015
   PubMed Web of Science ®Google Scholar
• Kalaitzopoulos DR, Samartzis N, Kolovos GN, et al. Treatment of endometriosis: a review with comparison of 8 guidelines. BMC Womens Health. 2021;21(1):397. doi:10.1186/s12905-021-01545-5
   PubMed Web of Science ®Google Scholar
• Qin Z, Dong Z, Liu J, et al. A preliminary study on the effects of black cohosh preparations on bone metabolism of rat models with GnRH-a-induced peri-menopausal symptoms. Front Endocrinol. 2022;13:854345. doi:10.3389/fendo.2022.854345
   PubMed Web of Science ®Google Scholar
• Chen J, Wang H, Dong Z, et al. GnRH-a-induced perimenopausal rat modeling and black cohosh preparations’ effect on rat’s reproductive endocrine. Front Endocrinol. 2021;12:683552. doi:10.3389/fendo.2021.683552
   PubMed Web of Science ®Google Scholar
• Corte LD, Noventa M, Ciebiera M, et al. Phytotherapy in endometriosis: an up-to-date review. J Complement Integr Med. 2020;17(3). doi:10.1515/jcim-2019-0084
   PubMedGoogle Scholar
• Zakhari A, Delpero E, McKeown S, Tomlinson G, Bougie O, Murji A. Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis. Hum Reprod Update. 2021;27(1):96–107. doi:10.1093/humupd/dmaa033
   PubMed Web of Science ®Google Scholar
• Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update. 2009;15(4):441–461. doi:10.1093/humupd/dmp007
   PubMed Web of Science ®Google Scholar
• Mikus M, Vitale SG, Coric M, et al. State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials. Gynecol Endocrinol. 2022;38(11):911–917. doi:10.1080/09513590.2022.2133105
   PubMed Web of Science ®Google Scholar
• Malaguarnera L. Influence of resveratrol on the immune response. Nutrients. 2019;11(5):946. doi:10.3390/nu11050946
   PubMed Web of Science ®Google Scholar
• Yuan L, Zhou M, Huang D, et al. Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑ mesenchymal transition via the AKT/GSK‑3β/Snail signaling pathway. Mol Med Rep. 2019;20(3):2783–2795. doi:10.3892/mmr.2019.10528
   PubMed Web of Science ®Google Scholar
• Galiniak S, Aebisher D, Bartusik-Aebisher D. Health benefits of resveratrol administration. Acta Biochim Pol. 2019;66(1):13–21. doi:10.18388/abp.2018_2749
   PubMed Web of Science ®Google Scholar
• Kasiotis KM, Pratsinis H, Kletsas D, Haroutounian SA. Resveratrol and related stilbenes: their anti-aging and anti-angiogenic properties. Food Chem Toxicol. 2013;61:112–120. doi:10.1016/j.fct.2013.03.038
   PubMed Web of Science ®Google Scholar
• Rodríguez-Enríquez S, Pacheco-Velázquez SC, Marín-Hernández Á, et al. Resveratrol inhibits cancer cell proliferation by impairing oxidative phosphorylation and inducing oxidative stress. Toxicol Appl Pharmacol. 2019;370:65–77. doi:10.1016/j.taap.2019.03.008
   PubMed Web of Science ®Google Scholar
• Fu X, Li M, Tang C, Huang Z, Najafi M. Targeting of cancer cell death mechanisms by resveratrol: a review. Apoptosis. 2021;26(11–12):561–573. doi:10.1007/s10495-021-01689-7
   PubMed Web of Science ®Google Scholar
• Burns J, Yokota T, Ashihara H, Lean ME, Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem. 2002;50(11):3337–3340. doi:10.1021/jf0112973
   PubMed Web of Science ®Google Scholar
• Sales JM, Resurreccion AV. Resveratrol in peanuts. Crit Rev Food Sci Nutr. 2014;54(6):734–770. doi:10.1080/10408398.2011.606928
   PubMed Web of Science ®Google Scholar
• Lyons MM, Yu C, Toma RB, et al. Resveratrol in raw and baked blueberries and bilberries. J Agric Food Chem. 2003;51(20):5867–5870. doi:10.1021/jf034150f
   PubMed Web of Science ®Google Scholar
• Sanders TH, McMichael RW Jr, Hendrix KW. Occurrence of resveratrol in edible peanuts. J Agric Food Chem. 2000;48(4):1243–1246. doi:10.1021/jf990737b
   PubMed Web of Science ®Google Scholar
• Shi J, Zeng Q, Liu Y, Pan Z. Alternaria sp. MG1, a resveratrol-producing fungus: isolation, identification, and optimal cultivation conditions for resveratrol production. Appl Microbiol Biotechnol. 2012;95(2):369–379. doi:10.1007/s00253-012-4045-9
   PubMed Web of Science ®Google Scholar
• Chen X, He H, Wang G, et al. Stereospecific determination of cis- and trans-resveratrol in rat plasma by HPLC: application to pharmacokinetic studies. Biomed Chromatogr. 2007;21(3):257–265. doi:10.1002/bmc.747
   PubMed Web of Science ®Google Scholar
• Camont L, Cottart CH, Rhayem Y, et al. Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions. Anal Chim Acta. 2009;634(1):121–128. doi:10.1016/j.aca.2008.12.003
   PubMed Web of Science ®Google Scholar
• Salehi B, Mishra AP, Nigam M, et al. Resveratrol: a double-edged sword in health benefits. Biomedicines. 2018;6(3). doi:10.3390/biomedicines6030091
   Web of Science ®Google Scholar
• Caruso F, Tanski J, Villegas-Estrada A, Rossi M. Structural basis for antioxidant activity of trans-resveratrol: ab initio calculations and crystal and molecular structure. J Agric Food Chem. 2004;52(24):7279–7285. doi:10.1021/jf048794e
   PubMed Web of Science ®Google Scholar
• Ovesná Z, Horváthová-Kozics K. Structure-activity relationship of trans-resveratrol and its analogues. Neoplasma. 2005;52(6):450–455.
   PubMed Web of Science ®Google Scholar
• Carter LG, D’Orazio JA, Pearson KJ. Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer. 2014;21(3):R209–R225. doi:10.1530/erc-13-0171
   PubMed Web of Science ®Google Scholar
• Zaffaroni N, Beretta GL. Resveratrol and prostate cancer: the power of phytochemicals. Curr Med Chem. 2021;28(24):4845–4862. doi:10.2174/0929867328666201228124038
   PubMed Web of Science ®Google Scholar
• Vernousfaderani EK, Akhtari N, Rezaei S, et al. Resveratrol and colorectal cancer: a molecular approach to clinical researches. Curr Top Med Chem. 2021;21(29):2634–2646. doi:10.2174/1568026621666211105093658
   PubMed Web of Science ®Google Scholar
• Sun X, Fu P, Xie L, et al. Resveratrol inhibits the progression of cervical cancer by suppressing the transcription and expression of HPV E6 and E7 genes. Int J Mol Med. 2021;47(1):335–345. doi:10.3892/ijmm.2020.4789
   PubMed Web of Science ®Google Scholar
• Wu JM, Hsieh TC. Resveratrol: a cardioprotective substance. Ann N Y Acad Sci. 2011;1215:16–21. doi:10.1111/j.1749-6632.2010.05854.x
   PubMed Web of Science ®Google Scholar
• Tan CS, Loh YC, Tew WY, Yam MF. Vasorelaxant effect of 3,5,4’-trihydroxy-trans-stilbene (resveratrol) and its underlying mechanism. Inflammopharmacology. 2020;28(4):869–875. doi:10.1007/s10787-019-00682-6
   PubMed Web of Science ®Google Scholar
• Rocha-González HI, Ambriz-Tututi M, Granados-Soto V. Resveratrol: a natural compound with pharmacological potential in neurodegenerative diseases. CNS Neurosci Ther. 2008;14(3):234–247. doi:10.1111/j.1755-5949.2008.00045.x
   PubMed Web of Science ®Google Scholar
• Amaya SC, Savaris RF, Filipovic CJ, et al. Resveratrol and endometrium: a closer look at an active ingredient of red wine using in vivo and in vitro models. Reprod Sci. 2014;21(11):1362–1369. doi:10.1177/1933719114525271
   PubMed Web of Science ®Google Scholar
• Saliba C, Jaafoury H, El Hajj M, Nicolas G, Haidar Ahmad H. Abdominal wall endometriosis: a case report. Cureus. 2019;11(2):e4061. doi:10.7759/cureus.4061
   PubMed Web of Science ®Google Scholar
• Janša V, Klančič T, Pušić M, et al. Proteomic analysis of peritoneal fluid identified COMP and TGFBI as new candidate biomarkers for endometriosis. Sci Rep. 2021;11(1):20870. doi:10.1038/s41598-021-00299-2
   PubMed Web of Science ®Google Scholar
• Jiang L, Wan Y, Feng Z, et al. Long noncoding RNA UCA1 is related to autophagy and apoptosis in endometrial stromal cells. Front Oncol. 2020;10:618472. doi:10.3389/fonc.2020.618472
   PubMed Web of Science ®Google Scholar
• Azam INA, Wahab NA, Mokhtar MH, Shafiee MN, Mokhtar NM. Roles of microRNAs in regulating apoptosis in the pathogenesis of endometriosis. Life. 2022;12(9):1321. doi:10.3390/life12091321
   PubMedGoogle Scholar
• Yerlikaya G, Balendran S, Pröstling K, et al. Comprehensive study of angiogenic factors in women with endometriosis compared to women without endometriosis. Eur J Obstet Gynecol Reprod Biol. 2016;204:88–98. doi:10.1016/j.ejogrb.2016.07.500
   PubMed Web of Science ®Google Scholar
• Ahn SH, Monsanto SP, Miller C, Singh SS, Thomas R, Tayade C. Pathophysiology and immune dysfunction in endometriosis. Biomed Res Int. 2015;2015:795976. doi:10.1155/2015/795976
   PubMed Web of Science ®Google Scholar
• Filip L, Duică F, Prădatu A, et al. Endometriosis associated infertility: a critical review and analysis on etiopathogenesis and therapeutic approaches. Medicina. 2020;56(9):460. doi:10.3390/medicina56090460
   PubMedGoogle Scholar
• Clower L, Fleshman T, Geldenhuys WJ, Santanam N. Targeting oxidative stress involved in endometriosis and its pain. Biomolecules. 2022;12(8):1055. doi:10.3390/biom12081055
   PubMed Web of Science ®Google Scholar
• Till SR, Nakamura R, Schrepf A, As-Sanie S. Approach to diagnosis and management of chronic pelvic pain in women: incorporating chronic overlapping pain conditions in assessment and management. Obstet Gynecol Clin North Am. 2022;49(2):219–239. doi:10.1016/j.ogc.2022.02.006
   PubMed Web of Science ®Google Scholar
• Crain DA, Janssen SJ, Edwards TM, et al. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil Steril. 2008;90(4):911–940. doi:10.1016/j.fertnstert.2008.08.067
   PubMed Web of Science ®Google Scholar
• Sophonsritsuk A, Tantanavipas S, Tingthanatikul Y, Lertvikool S, Dittharot K, Waiyaput W. Effects of ethinyl estradiol in combined oral contraceptives on cell proliferation and apoptosis in ectopic endometrial tissue: a randomized controlled study. J Fam Reprod Health. 2021;15(1):45–52. doi:10.18502/jfrh.v15i1.6077
   PubMedGoogle Scholar
• Bruner-Tran KL, Osteen KG, Taylor HS, Sokalska A, Haines K, Duleba AJ. Resveratrol inhibits development of experimental endometriosis in vivo and reduces endometrial stromal cell invasiveness in vitro. Biol Reprod. 2011;84(1):106–112. doi:10.1095/biolreprod.110.086744
   PubMed Web of Science ®Google Scholar
• Rudzitis-Auth J, Menger MD, Laschke MW. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis. Hum Reprod. 2013;28(5):1339–1347. doi:10.1093/humrep/det031
   PubMed Web of Science ®Google Scholar
• Delbandi AA, Mahmoudi M, Shervin A, Heidari S, Kolahdouz-Mohammadi R, Zarnani AH. Evaluation of apoptosis and angiogenesis in ectopic and eutopic stromal cells of patients with endometriosis compared to non-endometriotic controls. BMC Womens Health. 2020;20(1):3. doi:10.1186/s12905-019-0865-4
   PubMed Web of Science ®Google Scholar
• Wei WD, Ruan F, Tu FX, Zhou CY, Lin J. Expression of suppressor of cytokine signaling-3 and caspase-3 in endometriosis and their correlation. Zhonghua Bing Li Xue Za Zhi. 2013;42(8):515–518. doi:10.3760/cma.j.issn.0529-5807.2013.08.003
   PubMedGoogle Scholar
• Madanes D, Meresman G, Valla SA, et al. Resveratrol impairs cellular mechanisms associated with the pathogenesis of endometriosis. Reprod Biomed Online. 2022;44(6):976–990. doi:10.1016/j.rbmo.2022.02.008
   PubMed Web of Science ®Google Scholar
• Fan YZ, Zhang JT, Yang HC, Yang YQ. Expression of MMP-2, TIMP-2 protein and the ratio of MMP-2/TIMP-2 in gallbladder carcinoma and their significance. World J Gastroenterol. 2002;8(6):1138–1143. doi:10.3748/wjg.v8.i6.1138
   PubMed Web of Science ®Google Scholar
• Khazaei MR, Rashidi Z, Chobsaz F, Niromand E, Khazaei M. Inhibitory effect of resveratrol on the growth and angiogenesis of human endometrial tissue in an in vitro three-dimensional model of endometriosis. Reprod Biol. 2020;20(4):484–490. doi:10.1016/j.repbio.2020.07.012
   PubMed Web of Science ®Google Scholar
• Kolahdouz-Mohammadi R, Delbandi AA, Khodaverdi S, Arefi S, Arablou T, Shidfar F. The effects of resveratrol treatment on Bcl-2 and bax gene expression in endometriotic compared with non-endometriotic stromal cells. Iran J Public Health. 2020;49(8):1546–1554. doi:10.18502/ijph.v49i8.3900
   PubMed Web of Science ®Google Scholar
• Taguchi A, Koga K, Kawana K, et al. Resveratrol enhances apoptosis in endometriotic stromal cells. Am J Reprod Immunol. 2016;75(4):486–492. doi:10.1111/aji.12489
   PubMed Web of Science ®Google Scholar
• Dull AM, Moga MA, Dimienescu OG, Sechel G, Burtea V, Anastasiu CV. Therapeutic approaches of resveratrol on endometriosis via anti-inflammatory and anti-angiogenic pathways. Molecules. 2019;24(4):667. doi:10.3390/molecules24040667
   PubMed Web of Science ®Google Scholar
• Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98(3):511–519. doi:10.1016/j.fertnstert.2012.06.029
   PubMed Web of Science ®Google Scholar
• Thanatsis N, Filindris T, Siampalis A, et al. The effect of novel medical nonhormonal treatments on the angiogenesis of endometriotic lesions. Obstet Gynecol Surv. 2021;76(5):281–291. doi:10.1097/ogx.0000000000000888
   PubMed Web of Science ®Google Scholar
• Rocha ALL, Reis FM, Taylor RN. Angiogenesis and endometriosis. Obstet Gynecol Int. 2013;2013:859619. doi:10.1155/2013/859619
   PubMedGoogle Scholar
• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1(1):27–31. doi:10.1038/nm0195-27
   PubMed Web of Science ®Google Scholar
• Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol. 2011;27(1):563–584. doi:10.1146/annurev-cellbio-092910-154002
   PubMedGoogle Scholar
• McMahon G. VEGF receptor signaling in tumor angiogenesis. oncologist. 2000;5(Suppl 1):3–10. doi:10.1634/theoncologist.5-suppl_1-3
   PubMedGoogle Scholar
• Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176(6):1248–1264. doi:10.1016/j.cell.2019.01.021
   PubMed Web of Science ®Google Scholar
• Mahnke JL, Dawood MY, Huang JC. Vascular endothelial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis. Fertil Steril. 2000;73(1):166–170. doi:10.1016/s0015-0282(99)00466-5
   PubMed Web of Science ®Google Scholar
• Machado DE, Abrao MS, Berardo PT, Takiya CM, Nasciutti LE. Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum. Fertil Steril. 2008;90(1):148–155. doi:10.1016/j.fertnstert.2007.05.076
   PubMed Web of Science ®Google Scholar
• Bourlev V, Volkov N, Pavlovitch S, Lets N, Larsson A, Olovsson M. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction. 2006;132(3):501–509. doi:10.1530/rep.1.01110
   PubMed Web of Science ®Google Scholar
• Potlog-Nahari C, Stratton P, Winkel C, et al. Urine vascular endothelial growth factor-A is not a useful marker for endometriosis. Fertil Steril. 2004;81(6):1507–1512. doi:10.1016/j.fertnstert.2003.10.040
   PubMed Web of Science ®Google Scholar
• Young VJ, Ahmad SF, Duncan WC, Horne AW. The role of TGF-β in the pathophysiology of peritoneal endometriosis. Hum Reprod Update. 2017;23(5):548–559. doi:10.1093/humupd/dmx016
   PubMed Web of Science ®Google Scholar
• Young VJ, Brown JK, Maybin J, Saunders PT, Duncan WC, Horne AW. Transforming growth factor-β induced Warburg-like metabolic reprogramming may underpin the development of peritoneal endometriosis. J Clin Endocrinol Metab. 2014;99(9):3450–3459. doi:10.1210/jc.2014-1026
   PubMed Web of Science ®Google Scholar
• Young VJ, Brown JK, Saunders PT, Duncan WC, Horne AW, Dettman R. The peritoneum is both a source and target of TGF-β in women with endometriosis. PLoS One. 2014;9(9):e106773. doi:10.1371/journal.pone.0106773
   PubMed Web of Science ®Google Scholar
• Ricci AG, Olivares CN, Bilotas MA, et al. Natural therapies assessment for the treatment of endometriosis. Hum Reprod. 2013;28(1):178–188. doi:10.1093/humrep/des369
   PubMed Web of Science ®Google Scholar
• Cenksoy PO, Oktem M, Erdem O, et al. A potential novel treatment strategy: inhibition of angiogenesis and inflammation by resveratrol for regression of endometriosis in an experimental rat model. Gynecol Endocrinol. 2015;31(3):219–224. doi:10.3109/09513590.2014.976197
   PubMed Web of Science ®Google Scholar
• Bayoglu Tekin Y, Guven S, Kirbas A, Kalkan Y, Tumkaya L, Guvendag Guven ES. Is resveratrol a potential substitute for leuprolide acetate in experimental endometriosis? Eur J Obstet Gynecol Reprod Biol. 2015;184:1–6. doi:10.1016/j.ejogrb.2014.10.041
   PubMed Web of Science ®Google Scholar
• Ergenoğlu AM, Yeniel A, Erbaş O, et al. Regression of endometrial implants by resveratrol in an experimentally induced endometriosis model in rats. Reprod Sci. 2013;20(10):1230–1236. doi:10.1177/1933719113483014
   PubMed Web of Science ®Google Scholar
• Bahrami A, Ayen E, Razi M, Behfar M. Effects of atorvastatin and resveratrol against the experimental endometriosis; evidence for glucose and monocarboxylate transporters, neoangiogenesis. Life Sci. 2021;272:119230. doi:10.1016/j.lfs.2021.119230
   PubMed Web of Science ®Google Scholar
• Arablou T, Aryaeian N, Khodaverdi S, et al. The effects of resveratrol on the expression of VEGF, TGF-β, and MMP-9 in endometrial stromal cells of women with endometriosis. Sci Rep. 2021;11(1):6054. doi:10.1038/s41598-021-85512-y
   PubMed Web of Science ®Google Scholar
• Arablou T, Delbandi AA, Khodaverdi S, et al. Resveratrol reduces the expression of insulin-like growth factor-1 and hepatocyte growth factor in stromal cells of women with endometriosis compared with nonendometriotic women. Phytother Res. 2019;33(4):1044–1054. doi:10.1002/ptr.6298
   PubMed Web of Science ®Google Scholar
• Khodarahmian M, Amidi F, Moini A, et al. A randomized exploratory trial to assess the effects of resveratrol on VEGF and TNF-α 2 expression in endometriosis women. J Reprod Immunol. 2021;143(2021):103248. doi:10.1016/j.jri.2020.103248
   PubMedGoogle Scholar
• Lukács L, Kovács AR, Pál L, Szűcs S, Lampé R. Evaluating the phagocytic index of peripheral leukocytes in endometriosis by plasma experiments. Medicina. 2022;58(7):925. doi:10.3390/medicina58070925
   PubMedGoogle Scholar
• Yuan DP, Gu L, Long J, et al. Shikonin reduces endometriosis by inhibiting RANTES secretion and mononuclear macrophage chemotaxis. Exp Ther Med. 2014;7(3):685–690. doi:10.3892/etm.2013.1458
   PubMed Web of Science ®Google Scholar
• Tamai H, Kinugasa M, Nishio M, Miyake M. Peritoneal inclusion cysts treated with a levonorgestrel-releasing intrauterine system: a case report. Case Rep Womens Health. 2019;22:e00113. doi:10.1016/j.fertnstert.2008.08.067
   PubMedGoogle Scholar
• Kolahdouz-Mohammadi R, Shidfar F, Khodaverdi S, et al. Resveratrol treatment reduces expression of MCP-1, IL-6, IL-8 and RANTES in endometriotic stromal cells. J Cell Mol Med. 2021;25(2):1116–1127. doi:10.1111/jcmm.16178
   PubMed Web of Science ®Google Scholar
• Chopyak VV, Koval HD, Havrylyuk AM, Lishchuk-Yakymovych KA, Potomkina HA, Kurpisz MK. Immunopathogenesis of endometriosis - a novel look at an old problem. Cent Eur J Immunol. 2022;47(1):109–116. doi:10.5114/ceji.2022.113830
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang J, Zhang X. An update on the multifaceted role of NF-kappaB in endometriosis. Int J Biol Sci. 2022;18(11):4400–4413. doi:10.7150/ijbs.72707
   PubMed Web of Science ®Google Scholar
• Li MZ, Wu YH, Ali M, Wu XQ, Nie MF. Endometrial stromal cells treated by tumor necrosis factor-α stimulate macrophages polarized toward M2 via interleukin-6 and monocyte chemoattractant protein-1. J Obstet Gynaecol Res. 2020;46(2):293–301. doi:10.1111/jog.14135
   PubMed Web of Science ®Google Scholar
• Bacci M, Capobianco A, Monno A, et al. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol. 2009;175(2):547–556. doi:10.2353/ajpath.2009.081011
   PubMed Web of Science ®Google Scholar
• Wang C, Chen Z, Zhao X, et al. Transcriptome-based analysis reveals therapeutic effects of resveratrol on endometriosis in arat model. Drug Des Devel Ther. 2021;15:4141–4155. doi:10.2147/DDDT.S323790
   PubMed Web of Science ®Google Scholar
• Singh S, Anshita D, Ravichandiran V. MCP-1: function, regulation, and involvement in disease. Int Immunopharmacol. 2021;101(PtB):107598. doi:10.1016/j.intimp.2021.107598
   PubMedGoogle Scholar
• Borrelli GM, Abrão MS, Mechsner S. Can chemokines be used as biomarkers for endometriosis? A systematic review. Hum Reprod. 2014;29(2):253–266. doi:10.1093/humrep/det401
   PubMed Web of Science ®Google Scholar
• Heidari S, Kolahdouz-Mohammadi R, Khodaverdi S, Tajik N, Delbandi AA. Expression levels of MCP-1, HGF, and IGF-1 in endometriotic patients compared with non-endometriotic controls. BMC Womens Health. 2021;21(1):422. doi:10.1186/s12905-021-01560-6
   PubMed Web of Science ®Google Scholar
• Kang YJ, Jeung IC, Park A, et al. An increased level of IL-6 suppresses NK cell activity in peritoneal fluid of patients with endometriosis via regulation of SHP-2 expression. Hum Reprod. 2014;29(10):2176–2189. doi:10.1093/humrep/deu172
   PubMed Web of Science ®Google Scholar
• Song Y, Su RW, Joshi NR, et al. Interleukin-6 (IL-6) activates the NOTCH1 signaling pathway through E-proteins in endometriotic lesions. J Clin Endocrinol Metab. 2020;105(5):1316–1326. doi:10.1210/clinem/dgaa096
   PubMed Web of Science ®Google Scholar
• Piva M, Horowitz GM, Sharpe-Timms KL. Interleukin-6 differentially stimulates haptoglobin production by peritoneal and endometriotic cells in vitro: a model for endometrial-peritoneal interaction in endometriosis. J Clin Endocrinol Metab. 2001;86(6):2553–2561. doi:10.1210/jcem.86.6.7613
   PubMed Web of Science ®Google Scholar
• Carmona F, Chapron C, Martínez-Zamora M, et al. Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6. J Reprod Immunol. 2012;95(1–2):80–86. doi:10.1016/j.jri.2012.06.001
   PubMed Web of Science ®Google Scholar
• Li C, Zhao HL, Li YJ, et al. The expression and significance of leukemia inhibitory factor, interleukin-6 and vascular endothelial growth factor in Chinese patients with endometriosis. Arch Gynecol Obstet. 2021;304(1):163–170. doi:10.1007/s00404-021-05980-5
   PubMed Web of Science ®Google Scholar
• Delbandi AA, Mahmoudi M, Shervin A, et al. Eutopic and ectopic stromal cells from patients with endometriosis exhibit differential invasive, adhesive, and proliferative behavior. Fertil Steril. 2013;100(3):761–769. doi:10.1016/j.fertnstert.2013.04.041
   PubMed Web of Science ®Google Scholar
• Arici A, Tazuke SI, Attar E, Kliman HJ, Olive DL. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod. 1996;2(1):40–45. doi:10.1093/molehr/2.1.40
   PubMed Web of Science ®Google Scholar
• Santegoets KC, Wenink MH, van den Berg WB, Radstake TR, Bayry J. Fc gamma receptor IIb on GM-CSF macrophages controls immune complex mediated inhibition of inflammatory signals. PLoS One. 2014;9(10):e110966. doi:10.1371/journal.pone.0110966
   PubMed Web of Science ®Google Scholar
• Zhong YC, Zhou XF, Hou CM, Li WP. Effect of danefukang on symptoms and biomarkers in women with endometriosis. Taiwan J Obstet Gynecol. 2019;58(2):218–222. doi:10.1016/j.tjog.2019.01.009
   PubMed Web of Science ®Google Scholar
• Riccio LDGC, Santulli P, Marcellin L, Abrão MS, Batteux F, Chapron C. Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol. 2018;50:39–49. doi:10.1016/j.bpobgyn.2018.01.010
   PubMed Web of Science ®Google Scholar
• Kodarahmian M, Amidi F, Moini A, et al. The modulating effects of resveratrol on the expression of MMP-2 and MMP-9 in endometriosis women: a randomized exploratory trial. Gynecol Endocrinol. 2019;35(8):719–726. doi:10.1080/09513590.2019.1576612
   PubMed Web of Science ®Google Scholar
• Chu H, Li H, Guan X, et al. Resveratrol protects late endothelial progenitor cells from TNF-α-induced inflammatory damage by upregulating Krüppel-like factor-2. Mol Med Rep. 2018;17(4):5708–5715. doi:10.3892/mmr.2018.8621
   PubMed Web of Science ®Google Scholar
• Yu H, Pan C, Zhao S, Wang Z, Zhang H, Wu W. Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. Biomed Pharmacother. 2008;62(6):366–372. doi:10.1016/j.biopha.2007.09.006
   PubMed Web of Science ®Google Scholar
• Morita Y, Wada-Hiraike O, Yano T, et al. Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary. Reprod Biol Endocrinol. 2012;10(1):14. doi:10.1186/1477-7827-10-14
   PubMedGoogle Scholar
• Singh UP, Singh NP, Singh B, et al. Resveratrol (trans-3,5,4’-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis. J Pharmacol Exp Ther. 2010;332(3):829–839. doi:10.1124/jpet.109.160838
   PubMed Web of Science ®Google Scholar
• Kiernan R, Brès V, Ng RW, et al. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem. 2003;278(4):2758–2766. doi:10.1074/jbc.M209572200
   PubMed Web of Science ®Google Scholar
• Mehri F, Ranjbar A, Shirafkan N, Asl SS, Esfahani M. The protective effect of resveratrol on diazinon-induced oxidative stress and glucose hemostasis disorder in rats’ liver. J Biochem Mol Toxicol. 2022;37(7):e23063. doi:10.1002/jbt.23063
   Google Scholar
• Taguchi A, Wada-Hiraike O, Kawana K, et al. Resveratrol suppresses inflammatory responses in endometrial stromal cells derived from endometriosis: a possible role of the sirtuin 1 pathway. J Obstet Gynaecol Res. 2014;40(3):770–778. doi:10.1111/jog.12252
   PubMed Web of Science ®Google Scholar
• Lai ZZ, Yang HL, Ha SY, et al. Cyclooxygenase-2 in endometriosis. Int J Biol Sci. 2019;15(13):2783–2797. doi:10.7150/ijbs.35128
   PubMed Web of Science ®Google Scholar
• Cai X, Liu M, Zhang B, Zhao SJ, Jiang SW. Phytoestrogens for the management of endometriosis: findings and issues. Pharmaceuticals. 2021;14(6). doi:10.3390/ph14060569
   Web of Science ®Google Scholar
• Nanda A, Thangapandi K, Banerjee P, et al. Cytokines, angiogenesis, and extracellular matrix degradation are augmented by oxidative stress in endometriosis. Ann Lab Med. 2020;40(5):390–397. doi:10.3343/alm.2020.40.5.390
   PubMed Web of Science ®Google Scholar
• Maia JH, Haddad C, Pinheiro N, Casoy J. Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain. Int J Womens Health. 2012;4(1):543–549. doi:10.2147/IJWH.S36825
   PubMedGoogle Scholar
• da Silva DM, Gross LA, Neto EPG, Lessey BA, Savaris RF. The use of resveratrol as an adjuvant treatment of pain in endometriosis: a randomized clinical trial. J Endocrinol Soc. 2017;1(4):359–369. doi:10.1210/js.2017-00053
   PubMedGoogle Scholar
• Cacciottola L, Donnez J, Dolmans MM. Can endometriosis-related oxidative stress pave the way for new treatment targets? Int J Mol Sci. 2021;22(13):7138. doi:10.3390/ijms22137138
   PubMed Web of Science ®Google Scholar
• Lingappan K. NF-κB in oxidative stress. Curr Opin Toxicol. 2018;7:81–86. doi:10.1016/j.cotox.2017.11.002
   PubMedGoogle Scholar
• Van Langendonckt A, Casanas-Roux F, Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril. 2002;77(5):861–870. doi:10.1016/S0015-0282(02)02959-X
   PubMed Web of Science ®Google Scholar
• Gupta S, Agarwal A, Krajcir N, Alvarez JG. Role of oxidative stress in endometriosis. Reprod Biomed Online. 2006;13(1):126–134. 2291. doi:10.1016/S1472-6483(10)62026-3
   PubMed Web of Science ®Google Scholar
• Bach Knudsen KE, Lærke HN, Hedemann MS, et al. Impact of diet-modulated butyrate production on intestinal barrier function and inflammation. Nutrients. 2018;10(10):1499. doi:10.3390/nu10101499
   PubMed Web of Science ®Google Scholar
• González-Ramos R, Donnez J, Defrère S, et al. Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis. Mol Hum Reprod. 2007;13(7):503–509. doi:10.1093/molehr/gam033
   PubMed Web of Science ®Google Scholar
• Vallée A, Lecarpentier Y. Curcumin and endometriosis. Int J Mol Sci. 2020;21(7):2440. doi:10.3390/ijms21072440
   PubMed Web of Science ®Google Scholar
• Qiu XM, Lai ZZ, Ha SY, et al. IL-2 and IL-27 synergistically promote growth and invasion of endometriotic stromal cells by maintaining the balance of IFN-γ and IL-10 in endometriosis. Reproduction. 2020;159(3):251–260. doi:10.1530/rep-19-0411
   PubMed Web of Science ®Google Scholar
• Liu P, Pan Q. Butein inhibits oxidative stress injury in rats with chronic heart failure via ERK/Nrf2 signaling. Cardiovasc Ther. 2022;2022:8684014. doi:10.1155/2022/8684014
   PubMed Web of Science ®Google Scholar
• Yavuz S, Aydin N, Celik O, Yilmaz E, Ozerol E, Tanbek K. Resveratrol successfully treats experimental endometriosis through modulation of oxidative stress and lipid peroxidation. J Cancer Res. 2014;10(2):324–329. doi:10.4103/0973-1482.136619
   Google Scholar
• Sampson JA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927;14:422–469. doi:10.1016/S0002-9378(15)30003-X
   Google Scholar
• Jana S, Rudra DS, Paul S, Swarnakar S. Curcumin delays endometriosis development by inhibiting MMP-2 activity. Indian J Biochem Biophys. 2012;49(5):342–348.
   PubMed Web of Science ®Google Scholar
• Vihinen P, Ala-Aho R, Kähäri VM. Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets. 2005;5(3):203–220. doi:10.2174/1568009053765799
   PubMed Web of Science ®Google Scholar
• Zakiyanov O, Kalousová M, Zima T, Tesař V. Matrix metalloproteinases in renal diseases: a critical appraisal. Kidney Blood Press Res. 2019;44(3):298–330. doi:10.1159/000499876
   PubMed Web of Science ®Google Scholar
• Ke J, Ye J, Li M, Zhu Z. The role of matrix metalloproteinases in endometriosis: a potential target. Biomolecules. 2021;11(11):1739. doi:10.3390/biom11111739
   PubMed Web of Science ®Google Scholar
• Simões G, Pereira T, Caseiro A. Matrix metaloproteinases in vascular pathology. Microvasc Res. 2022;143:104398. doi:10.1016/j.mvr.2022.104398
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang C, Lin C, et al. Lipidomic alterations and PPARα activation induced by resveratrol lead to reduction in lesion size in endometriosis models. Oxid Med Cell Longev. 2021;2021:9979953. doi:10.1155/2021/9979953
   PubMed Web of Science ®Google Scholar
• Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178–196. doi:10.1038/nrm3758
   PubMed Web of Science ®Google Scholar
• Li L, Liu J, Xue H, et al. A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis. Oncogene. 2020;39(10):2125–2139. doi:10.1038/s41388-019-1132-8
   PubMed Web of Science ®Google Scholar
• Xu X, Kong X, Liu T, et al. Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway. Gynecol Oncol. 2019;154(1):207–217. doi:10.1016/j.ygyno.2019.04.005
   PubMed Web of Science ®Google Scholar
• Kong X, Xu X, Zhou L, et al. MTA1, a target of resveratrol, promotes epithelial-mesenchymal transition of endometriosis via ZEB2. Mol Ther Methods Clin Dev. 2020;19:295–306. doi:10.1016/j.omtm.2020.09.013
   PubMed Web of Science ®Google Scholar
• Renda G, Gökkaya İ, Şöhretoğlu D. Immunomodulatory properties of triterpenes. Phytochem Rev. 2022;21(2):537–563. doi:10.1007/s11101-021-09785-x
   PubMed Web of Science ®Google Scholar
• Correa FJS, Andres MP, Rocha TP, et al. Invariant natural killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis. Clinics. 2022;77:100032. doi:10.1016/j.clinsp.2022.100032
   PubMed Web of Science ®Google Scholar
• Huhtinen K, Desai R, Ståhle M, et al. Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels. J Clin Endocrinol Metab. 2012;97(11):4228–4235. doi:10.1210/jc.2012-1154
   PubMed Web of Science ®Google Scholar
• Chantalat E, Valera MC, Vaysse C, et al. Estrogen receptors and endometriosis. Int J Mol Sci. 2020;21(8):2815. doi:10.3390/ijms21082815
   PubMed Web of Science ®Google Scholar
• Gołąbek A, Kowalska K, Olejnik A. Polyphenols as a diet therapy concept for endometriosis— current opinion and future perspectives. Nutrients. 2021;13(4). doi:10.3390/nu13041347
   Web of Science ®Google Scholar
• Houshdaran S, Oke AB, Fung JC, Vo KC, Nezhat C, Giudice LC. Steroid hormones regulate genome-wide epigenetic programming and gene transcription in human endometrial cells with marked aberrancies in endometriosis. PLoS Genet. 2020;16(6):e1008601. doi:10.1371/journal.pgen.1008601
   PubMed Web of Science ®Google Scholar
• Chen P, Li B, Ou-Yang L. Role of estrogen receptors in health and disease. Front Endocrinol. 2022;13:839005. doi:10.3389/fendo.2022.839005
   PubMed Web of Science ®Google Scholar
• Xue Q, Lin Z, Cheng YH, et al. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod. 2007;77(4):681–687. doi:10.1095/biolreprod.107.061804
   PubMed Web of Science ®Google Scholar
• Han SJ, Jung SY, Wu SP, et al. Estrogen receptor β modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis. Cell. 2015;163(4):960–974. doi:10.1016/j.cell.2015.10.034
   PubMed Web of Science ®Google Scholar
• Yang KR, Yu HC, Huang CY, et al. Bioprocessed production of resveratrol-enriched rice wine: simultaneous rice wine fermentation, extraction, and transformation of piceid to resveratrol from Polygonum cuspidatum roots. Foods. 2019;8(7):258. doi:10.3390/foods8070258
   PubMed Web of Science ®Google Scholar
• Walle T. Bioavailability of resveratrol. Ann N Y Acad Sci. 2011;1215:9–15. doi:10.1111/j.1749-6632.2010.05842.x
   PubMed Web of Science ®Google Scholar
• Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther. 2002;302(1):369–373. doi:10.1124/jpet.102.033340
   PubMed Web of Science ®Google Scholar
• Henry-Vitrac C, Desmoulière A, Girard D, Mérillon JM, Krisa S. Transport, deglycosylation, and metabolism of trans-piceid by small intestinal epithelial cells. Eur J Nutr. 2006;45(7):376–382. doi:10.1007/s00394-006-0609-8
   PubMed Web of Science ®Google Scholar
• Wenzel E, Somoza V. Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res. 2005;49(5):472–481. doi:10.1002/mnfr.200500010
   PubMed Web of Science ®Google Scholar
• Singh CK, Ndiaye MA, Ahmad N. Resveratrol and cancer: challenges for clinical translation. Biochim Biophys Acta. 2015;1852(6):1178–1185. doi:10.1016/j.bbadis.2014.11.004
   PubMed Web of Science ®Google Scholar
• Chimento A, De Amicis F, Sirianni R, et al. Progress to improve oral bioavailability and beneficial effects of resveratrol. Int J Mol Sci. 2019;20(6):1381. doi:10.3390/ijms20061381
   PubMed Web of Science ®Google Scholar
• Tsai MJ, Lu IJ, Fu YS, Fang YP, Huang YB, Wu PC. Nanocarriers enhance the transdermal bioavailability of resveratrol: in-vitro and in-vivo study. Colloids Surf B Biointerfaces. 2016;148:650–656. doi:10.1016/j.colsurfb.2016.09.045
   PubMed Web of Science ®Google Scholar
• Lin YC, Hu SC, Huang PH, Lin TC, Yen FL. Electrospun resveratrol-loaded polyvinylpyrrolidone/cyclodextrin nanofibers and their biomedical applications. Pharmaceutics. 2020;12(6):552. doi:10.3390/pharmaceutics12060552
   PubMed Web of Science ®Google Scholar
• Summerlin N, Soo E, Thakur S, Qu Z, Jambhrunkar S, Popat A. Resveratrol nanoformulations: challenges and opportunities. Int J Pharm. 2015;479(2):282–290. doi:10.1016/j.ijpharm.2015.01.003
   PubMed Web of Science ®Google Scholar
• Guo W, Li A, Jia Z, Yuan Y, Dai H, Li H. Transferrin modified PEG-PLA-resveratrol conjugates: in vitro and in vivo studies for glioma. Eur J Pharmacol. 2013;718(1–3):41–47. doi:10.1016/j.ejphar.2013.09.034
   PubMed Web of Science ®Google Scholar
• Edwards JA, Beck M, Riegger C, Bausch J. Safety of resveratrol with examples for high purity, trans-resveratrol, resVida(®). Ann N Y Acad Sci. 2011;1215:131–137. doi:10.1111/j.1749-6632.2010.05855.x
   PubMed Web of Science ®Google Scholar
• Zhong LX, Wu ML, Li H, Liu J, Lin LZ. Efficacy and safety of intraperitoneally administered resveratrol against rat orthotopic ovarian cancers. Cancer Manag Res. 2019;11:6113–6124. doi:10.2147/cmar.S206301
   PubMed Web of Science ®Google Scholar
• Szende B, Tyihák E, Király-Véghely Z. Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures. Exp Mol Med. 2000;32(2):88–92. doi:10.1038/emm.2000.16
   PubMed Web of Science ®Google Scholar
• Wu H, Chen L, Zhu F, Han X, Sun L, Chen K. The cytotoxicity effect of resveratrol: cell cycle arrest and induced apoptosis of breast cancer 4T1 cells. Toxins. 2019;11(12):731. doi:10.3390/toxins11120731
   PubMed Web of Science ®Google Scholar
• Johnson WD, Morrissey RL, Usborne AL, et al. Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food Chem Toxicol. 2011;49(12):3319–3327. doi:10.1016/j.fct.2011.08.023
   PubMed Web of Science ®Google Scholar
• Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS. Resveratrol-associated renal toxicity. Toxicol Sci. 2004;82(2):614–619. doi:10.1093/toxsci/kfh263
   PubMed Web of Science ®Google Scholar
• Liu S, Zhao M, Zhou Y, et al. Resveratrol exerts dose-dependent anti-fibrotic or pro-fibrotic effects in kidneys: a potential risk to individuals with impaired kidney function. Phytomedicine. 2019;57:223–235. doi:10.1016/j.phymed.2018.12.024
   PubMed Web of Science ®Google Scholar
• Shaito A, Posadino AM, Younes N, et al. Potential adverse effects of resveratrol: a literature review. Int J Mol Sci. 2020;21(6):2084. doi:10.3390/ijms21062084
   PubMed Web of Science ®Google Scholar
• Amiot MJ, Romier B, Dao TM, et al. Optimization of trans-resveratrol bioavailability for human therapy. Biochimie. 2013;95(6):1233–1238. doi:10.1016/j.biochi.2013.01.008
   PubMed Web of Science ®Google Scholar
• Howells LM, Berry DP, Elliott PJ, et al. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res. 2011;4(9):1419–1425. doi:10.1158/1940-6207.Capr-11-0148
   PubMed Web of Science ®Google Scholar
• la Porte C, Voduc N, Zhang G, et al. Steady-state pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin Pharmacokinet. 2010;49(7):449–454. doi:10.2165/11531820-000000000-00000
   PubMed Web of Science ®Google Scholar
• Almeida L, Vaz-da-Silva M, Falcão A, et al. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res. 2009;53(Suppl 1):S7–S15. doi:10.1002/mnfr.200800177
   PubMedGoogle Scholar
• Boocock DJ, Faust GE, Patel KR, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1246–1252. doi:10.1158/1055-9965.Epi-07-0022
   PubMed Web of Science ®Google Scholar
• Sergides C, Chirilă M, Silvestro L, Pitta D, Pittas A. Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers. Exp Ther Med. 2016;11(1):164–170. doi:10.3892/etm.2015.2895
   PubMed Web of Science ®Google Scholar
• Singh AP, Singh R, Verma SS, et al. Health benefits of resveratrol: evidence from clinical studies. Med Res Rev. 2019;39(5):1851–1891. doi:10.1002/med.21565
   PubMed Web of Science ®Google Scholar